1156 Deaths Following COVID Vaccination In The Country: Govt

New Delhi : Rajasthan has reported 36 deaths following COVID-19 vaccination till March 15, 2023, according to a reply provided by the Union government in the Lok Sabha last week.
The state also witnessed 1737 Adverse Events Following Immunisation (AEFI), following COVID vaccination, the Union ministry of health and family welfare said in reply to a question by Kuruva Gorantla Madhav, a YSR Congress MP from Andhra Pradesh.

Country witnessed 92,479 cases of  Minor, Severe & Serious AEFI cases following COVID-19 vaccination reported till 15th March 2023.

The MP had sought details of the state-wise number of AEFI, including minor, severe and serious cases and the number of AEFI-related deaths. In his reply, the minister of state for health and family welfare Bharati Pravin Pawar said AEFI cases of COVID vaccines are reported and monitored through a well-structured and robust AEFI surveillance system under the Universal Immunisation Program.

For the reporting of COVID vaccination-related AEFIs, the SAFEVAC (a web-based application for AEFI) is integrated into CoWin and reporting of AEFIs is done through the Co-Win SAFEVAC. The app has the provision of reporting AEFIs by the vaccinator, district immunization officer and the beneficiary themselves.

According to the written reply, a total of 1,156 deaths following vaccination have been reported in the country. Kerala reported the highest deaths at 244. Maharashtra (102), Uttar Pradesh (86) and Madhya Pradesh (85) are the other states that reported more deaths than Karnataka.

Asked about the particulars of the AEFI cases, health commissioner D Randeep said he has sought details from the officials in the health department.
  • Related Posts

    • Pharma
    • April 7, 2025
    • 41 views
    Sun Pharma launches Fexuprazan tablets for Erosive Esophagitis treatment

    Sun Pharmaceutical Industries on Monday said it has introduced a medication for the treatment of Erosive Esophagitis of all grades. The Mumbai-based drug major, in a statement, said it has…

    • Pharma
    • April 7, 2025
    • 107 views
    Sun-Ranbaxy $4 billion merger completed

    NEW DELHI:  Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries today said merger of Ranbaxy with itself has been ‘consummated’ following receipt of requisite approvals. In…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Sun Pharma launches Fexuprazan tablets for Erosive Esophagitis treatment

    Sun Pharma launches Fexuprazan tablets for Erosive Esophagitis treatment

    Sun-Ranbaxy $4 billion merger completed

    Sun-Ranbaxy $4 billion merger completed

    Dr Reddy’s gets over Rs 2,395 crore show cause notice from I-T authority

    Dr Reddy’s gets over Rs 2,395 crore show cause notice from I-T authority

    ‘Made in India’ Stents win major victory against Import Lobby

    ‘Made in India’ Stents win major victory against Import Lobby